WuXi XDC Cayman (HKSE:02268) Accounts Payable & Accrued Expense : HK$871 Mil (As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is WuXi XDC Cayman Accounts Payable & Accrued Expense?

WuXi XDC Cayman's quarterly accounts payable & accrued expense increased from Dec. 2022 (HK$876 Mil) to Mar. 2023 (HK$925 Mil) but then declined from Mar. 2023 (HK$925 Mil) to Jun. 2023 (HK$871 Mil).

WuXi XDC Cayman's annual accounts payable & accrued expense declined from Dec. 2021 (HK$1,009 Mil) to Dec. 2022 (HK$876 Mil) but then increased from Dec. 2022 (HK$876 Mil) to Dec. 2023 (HK$1,022 Mil).

WuXi XDC Cayman Accounts Payable & Accrued Expense Historical Data

The historical data trend for WuXi XDC Cayman's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi XDC Cayman Accounts Payable & Accrued Expense Chart

WuXi XDC Cayman Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

38.03

1,008.81

876.42

1,021.95

WuXi XDC Cayman Quarterly Data
	Dec20	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial			-	876.42	925.23	870.51	1,021.95

WuXi XDC Cayman Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

WuXi XDC Cayman (HKSE:02268) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (HKSE:02268) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

L74:Germany

Address

No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN

Website

WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.

WuXi XDC Cayman (HKSE:02268) Headlines

No Headlines